- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- April 2023
- 112 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2024
- 137 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2024
- 358 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- September 2022
- 104 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 104 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €20914EUR$22,000USD£17,570GBP
- Report
- November 2023
- 230 Pages
Global
From €3508EUR$3,690USD£2,947GBP
- Book
- April 2019
- 1008 Pages
The Ischemic Attack market within the context of Cardiology is focused on the diagnosis and treatment of ischemic heart disease, which is caused by a lack of blood flow to the heart. This can lead to a heart attack, stroke, or other cardiovascular events. Treatment options include lifestyle changes, medications, and procedures such as angioplasty and stenting. The goal of treatment is to reduce the risk of future events and improve quality of life.
The Ischemic Attack market is highly competitive, with a range of products and services available from a variety of companies. These include medical device manufacturers, pharmaceutical companies, and healthcare providers. Examples of companies in this market include Medtronic, Abbott, Boston Scientific, Johnson & Johnson, and St. Jude Medical. Show Less Read more
